Emflaza Interactions
There are 578 drugs known to interact with Emflaza (deflazacort), along with 18 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 150 are major, 417 are moderate, and 11 are minor.
- View all 578 medications that may interact with Emflaza
- View Emflaza alcohol/food interactions (2)
- View Emflaza disease interactions (18)
Most frequently checked interactions
View interaction reports for Emflaza (deflazacort) and the medicines listed below.
- acetaminophen
- Blincyto (blinatumomab)
- calcium carbonate
- cefazolin
- cholecalciferol
- Cymbalta (duloxetine)
- Cytoxan (cyclophosphamide)
- diphenhydramine
- Duvyzat (givinostat)
- Emla (lidocaine / prilocaine topical)
- Entresto (sacubitril / valsartan)
- Exondys 51 (eteplirsen)
- fluoxetine
- ibuprofen
- Imbruvica (ibrutinib)
- Imfinzi (durvalumab)
- Jardiance (empagliflozin)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- lansoprazole
- lisinopril
- metformin
- multivitamin
- Nutropin AQ (somatropin)
- Ofev (nintedanib)
- prednisone
- spironolactone
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- testosterone
- Vitamin D3 (cholecalciferol)
Emflaza alcohol/food interactions
There are 2 alcohol/food interactions with Emflaza (deflazacort).
Emflaza disease interactions
There are 18 disease interactions with Emflaza (deflazacort) which include:
- (+) tuberculin test
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hypothyroidism
- MI
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- strongyloidiasis
- thromboembolism
- hepatic impairment
- infections
Report options
More about Emflaza (deflazacort)
- Emflaza consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Viltepso
Viltepso (viltolarsen) is used for the treatment of Duchenne muscular dystrophy (DMD) treatable ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Golodirsen
Golodirsen is used to treat Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Givinostat
Givinostat (Duvyzat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Eteplirsen
Eteplirsen is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a gene ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
